Details werden geladen...
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
CAMBRIDGE, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on August 1, 2026, it awarded inducement grants to eight new employees under Intellia’s 2024 Inducement Plan, as amended, as a material inducement to employment.
Ähnliche Seiten
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2359852
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/07/tmt-newswire/globenewswire/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2379345Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/08/04/tmt-newswire/globenewswire/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2397441Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/25/tmt-newswire/globenewswire/dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2391292Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/11/tmt-newswire/globenewswire/korro-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2382608